"AXIS Clinicals, a well established full-service CRO (Contract Research Organization) headquartered in Hyderabad, India; is an efficient, metric- based clinical research organization with a global footprint of operations (India, United States and Mexico)."

During the past decade, AXIS Clinicals Limited conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AXIS Clinicals Limited" are "Healthy" (4 trials). Many other conditions were trialed in "AXIS Clinicals Limited" in a lesser frequency.

Most popular intervention types in "AXIS Clinicals Limited" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Montelukast sodium" (2 trials) and "Rabeprazole sodium 20 mg Delayed Release tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "AXIS Clinicals Limited" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "AXIS Clinicals Limited". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in AXIS Clinicals Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AXIS Clinicals Limited, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".